Related Experiment Video
Updated: May 25, 2026

05:54
MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor
Published on: December 13, 2017
Surgical therapy for multiple sclerosis tremor: a 12-year follow-up study
A Hassan1, J E Ahlskog, M Rodriguez
1Department of Neurology, Mayo Clinic, Rochester, MN, USA.
European Journal of Neurology
|January 18, 2012
Summary
Surgery for severe multiple sclerosis (MS) tremor provided short-term relief, with tremor recurrence within months. Long-term outcomes show poor prognosis, with significant disability and mortality in MS tremor patients.
Area of Science:
- Neurology
- Neurosurgery
- Medical Technology
Background:
- Severe tremor in multiple sclerosis (MS) significantly impacts patient disability.
- Medications are often ineffective for managing MS-related tremor.
- Neurosurgical interventions like deep brain stimulation (DBS) and thalamotomy offer potential tremor suppression, but long-term efficacy is not well-established.
Purpose of the Study:
- To evaluate the long-term outcomes of surgical interventions for severe MS tremor.
- To assess tremor control, disability progression, and survival rates 12 years post-surgery.
Main Methods:
- A prospective 12-year follow-up study of nine patients with MS tremor who underwent either thalamotomy or DBS.
- Disability measures were recorded at baseline and 12 months post-surgery.
- Long-term data collection included tremor status, disability progression (Expanded Disability Status Scale), and mortality.
Main Results:
- Initial surgical success was observed in all patients, but tremor recurred in the median of 3 months.
- Median tremor-free survival was 4.3%, with two DBS patients achieving 5-year tremor suppression.
- At 12 years, survivors remained severely disabled (EDSS 8-8.5), and five patients had died, with a median post-operative survival of 5.8 years.
Conclusions:
- Surgical interventions for severe MS tremor offer limited long-term benefit, with a median duration of relief of only 3 months.
- The study highlights a poor long-term prognosis, characterized by progressive disability and increased mortality.
- Findings underscore the need for cautious consideration of long-term outcomes in future surgical trials for MS tremor.
More Related Videos
Related Concept Videos
Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...

